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1. Introduction 
Lactic acid bacteria (LAB) are Gram-positive microorganisms that produce lactic acid as a 
major product of their metabolism. Among them the genus Lactobacillus comprises a large 
heterogeneous group of low G+C DNA content, anaerobic and nonsporulating bacteria, that 
includes species widely used in the food industry. They play key roles in fermented dairy, 
meats and vegetables products. Due to their claimed health-promoting properties certain 
lactobacilli species are used as probiotics and they are commonly applied to dairy and 
functional foods products. Lactobacilli have a relatively simple fermentative metabolism 
focused to rapidly convert carbohydrates into lactic acid, and exhibited a limited 
biosynthetic capacity. In addition, several tools and strategies to manipulate them 
genetically are available. All those characteristics make lactobacilli specially suited for 
genetic engineering aimed to increase existing compounds or to produce novel metabolites 
of interest for the food industry. Regarding probiotic lactobacilli, through genetic 
manipulation, the health attributes of probiotic strains can be enhanced or new probiotic 
activities can be developed and additionally, an understanding of the underlying molecular 
mechanisms can be obtained. Here, we review metabolic engineering strategies in 
lactobacilli that have successfully been used to efficiently reroute sugar metabolism to 
compounds such as L-lactic acid, aroma compounds (acetoin, diacetyl), low-calorie sugars 
(mannitol, sorbitol) and exopolysaccharides. We will also describe strains of probiotic 
lactobacilli that have been developed to exploit their adherence and immunomodulatory 
properties, and to delivery proteins at the intestinal mucosa.  
1.1 Metabolic potential of lactobacilli 
Because of their fermentative metabolism and global utilization in food fermentations, LAB 
are specially suited for rerouting sugar metabolism to produce industrially important food 
compounds. During fermentation, monosaccharides are catabolized through glycolysis 
(Embden-Meyerhoff pathway) and related pathways (Figure 1). Glycolytic catabolism of 
sugars involves phosphorylation reactions that drive hexoses to fructose-1,6-bisP, which is 
then hydrolysed to glyceraldehyde-3P (GADH-3P) and dihydroxyacetone-P. Then, GADH-
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3P undertakes dephosphorylation and oxidation, which yields 2 pyruvate, 2 ATP and the 
reduction of 2 NAD+ to 2 NADH per glucose. Under normal metabolic conditions NADH is 
used mainly to reduce pyruvate. Some LAB exclusively produce lactate from pyruvate 
(homofermentative), while other species (heterofermentative) produce lactate, acetate, 
ethanol and CO2. There are other differences in heterofermentative species, since they can 
shift sugar catabolism towards the so called pentose phosphate or phosphoketolase 
pathway that renders GADH-3P and acetyl-P. Then, GADH-3P enters the lower part of the 
glycolysis. In this pathway two additional NADH molecules are oxidised by means of 
alcohol dehydrogenase that produces ethanol from acetyl-CoA. Therefore, the global 
balance of the heterofermentation of one mol of glucose is one mol of lactate, one mol of 
ethanol and one mol of CO2, with a net energy yield of one mol of ATP. 
An important strategy frequently used during metabolic engineering consists in blocking 
the formation of natural proton sinks, such as lactate or ethanol in the final steps of 
glycolysis. However, dissipation of the H+ pool has such a great relevance that LAB 
normally has several isoenzymes of L-lactate dehydrogenase (L-LDH) as showed by the 
analysis of different genomes such as Lactobacillus plantarum and Lactobacillus casei 
(Kleerebezem et al., 2003; Rico et al., 2008), and alternative dehydrogenases yielding D-
lactate have been found in most LAB genomes. An additional difficulty is imposed by the 
fact that glycolysis is subject to a strict allosteric regulation by its own intermediate and final 
metabolites, as well as by Pi, fructose-1,6bisP, phosphoenolpyruvate (PEP), ADP, ATP and 
NADH/NAD+ ratio. Its robustness and flexibility would assure an efficient bacterial 
growth, so that its activity rate would always respond to the cell’s energy demand. It has 
also been observed that there are three enzyme activities especially sensitive to allosteric 
modulation, which are most relevant in the pathway’s regulation and they are: 
phosphofructokinase (PFK), GADH-3P dehydrogenase and pyruvate kinase. PFK is strongly 
inhibited by PEP and pyruvate kinase activity is inhibited by Pi in Lactococcus lactis and this 
enzyme is stimulated by ADP and fructose-1,6bisP in Lactobacillus bulgaricus (Branny et al., 
1998). Furthermore, in L. lactis, GADH-3P dehydrogenase has a remarkable role in the 
modulation of the carbon flux, which is regulated by the NADH/NAD+ ratio, as it happens 
with LDH (Garrigues et al., 1997).  
LAB suitability as starter cultures in dairy fermentations highly depends on their ability to 
produce small concentrations of volatile compounds derived from the alternative 
metabolism of pyruvate. The production of diacetyl and acetoin is quite common in LAB. 
These compounds are produced through decarboxylation of -acetolactate obtained from 
pyruvate by the enzyme -acetolactate syntase (Figure 2). Additionally, under substrate 
limitation and anaerobiosis, the enzyme pyruvate-formate lyase produces acetyl-CoA and 
formate from pyruvate and CoA. Acetyl-CoA is an important metabolite, as it can be used as 
electron acceptor to oxidise NADH or as energy compound to obtain ATP. The enzymatic 
complex of pyruvate dehydrogenase also produces acetyl-CoA, CO2 and NADH from 
pyruvate, coenzyme A and NAD+. Under aerobic conditions, this is an anabolic enzyme 
producing acetyl-CoA used for lipid synthesis, but under aerobic conditions, it also has a 
catabolic function where NADH oxidases can regenerate the excess of NADH produced. 
Pyruvate oxidase mediates  onversion of pyruvate to acetyl-P, CO2 and H2O2. This activity 
allows to obtain ATP when carbon sources are limiting, by substrate level phosphorylation 
of acetyl-P.  
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Fig. 1. Scheme of glycolysis, phosphoketolase pathway and anabolic pathway of UDP-
sugars in LAB. [1] glucokinase, [2] phosphoglucose isomerase, [3] phosphofructokinase, [4] 
fructose 1,6-bisP aldolase, [5] triose-phosphate isomerase, [6] glyceraldehyde-3P 
dehydrogenase, [7] phosphoglycerate kinase, [8] pyruvate kinase, [9] lactate dehydrogenase, 
[10] hexokinase, [11] glucose-6P dehydrogenase, [12] 6-phosphogluconate dehydrogenase, 
[13] ribulose-5P 3-epimerase, [14] xylulose-5P phosphoketolase, [15] phosphotransacetylase, 
[16] acetaldehyde dehydrogenase, [17] alcohol dehydrogenase, [18] acetate kinase, [19]-
phosphoglucomutase, [20] UDP-glucose pyrophosphorylase, [21] UDP-galactose 4-
epimerase, [22] deoxyTDP-glucose pyrophosphorylase, [23] deoxyTDP-glucose 4,6-
dehydratase, [24] deoxyTDP-rhamnose synthetic enzyme system. PTS, PEP 
phosphotransferase system; Per: permease; CoA, coenzyme A; DHAP, dihydroxiacetone 
phosphate; GADH-3P, glyceraldehyde-3-phosphate; UDP-Glu, UDP-glucose; UDP-Gal, 
UDP-galactose; dTDP-Glu, deoxyTDP-glucose; dTDP-kdMan, deoxyTDP-4-keto-6-
deoxymannose; EPS, exopolysaccharide; PEP, phosphoenolpyruvate. 
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1.2 Functional properties of lactobacilli 
Bacterial populations in the gut of vertebrates have evolved through millions of years to 
render interdependent functions. They have been studied for long time using classical 
culturing techniques and recently through molecular approaches and it soon became 
evident that in humans, the gut’s microbioma is formed by numerous bacterial species 
whose proportions change between individuals (Eckburg et al., 2005). The most abundant 
genera are Bacteroides, Faecalibacterium or Bifidobacterium, however, although lactobacilli are 
not as abundant, they have been proved to play a remarkable role sustaining the global 
population balance and interact at different levels with the intestinal mucosa. In this 
environment some strains exerted beneficial health effects and they are considered 
probiotics. These are defined as live microorganisms that, when administered in adequate 
amounts, confer a beneficial effect on the health of the host (FAO/WHO, 2001). In addition 
to probiotics, functional food ingredients also include prebiotics, which are define as 
selectively fermented ingredients that allow specific changes in the composition and/or 
activity of the gastrointestinal microbiota that confer benefits upon host wellbeing and 
health (Roberfroid, 2007). Several beneficial effects of lactobacilli on human host have been 
reported. Strains of Lactobacillus rhamnosus, Lactobacillus acidophilus and L. bulgaricus alone or 
in combination are effectives in reduce the risk of acute infectious diarrhoea and prevent 
antibiotic-associated diarrhoea (Sazawal et al., 2006). A mixture of probiotics including 
lactobacilli seems effective in the maintenance of remission of intestinal bowel diseases such 
as chronic pouchitis and ulcerative colitis, and to decrease symptoms in patient with 
irritable bowel syndrome (Haller et al., 2010). A synbiotic food composed of the prebiotic 
oligofructose-enriched inulin, L. rhamnosus GG and Bifidobacterium lactic Bb12 was able to 
alter favourably several colorectal cancer markers in patients with cancer of colon (Rafter et 
al., 2007). Besides to gastrointestinal disorders, lactobacilli have also showed positive effects 
in other pathologies, such as in the treatment and prevention of bacterial vaginosis (Falagas 
et al., 2007), the prevention of atopic eczema (Tang et al., 2010) and prevention of dental 
caries (Stamatova & Meurman, 2009). The health promoting effects of probiotic bacteria are 
mediated mainly by three mechanisms, (i) microbe-microbe interactions; (ii) beneficial 
interactions with gut epithelium and (iii) immunomodulatory interactions (Lebeer et al., 
2008). Regarding the first mechanism, probiotics can have a beneficial effect on the host by 
modifying the microbiota trough competition and cooperation for nutrients, production of 
antimicrobial compounds (lactic acid, bacteriocins, H2O2), competition with pathogens for 
attachment sites to the host mucosal surface and by bacterial cell-host cell communication. 
With respect to the beneficial interactions of probiotics with gut epithelium, this constitutes 
the main target tissue of probiotic action, and Lactobacillus molecules can modify it by 
affecting the metabolic and barrier functions of the epithelial cells. The preservation of the 
epithelial barrier by probiotic lactobacilli has been attributed to induction of mucin 
secretion, enhancement of tight-junction functioning, upregulation of cytoprotective heat-
shock proteins and prevention of apoptosis of ephitelial cells. 
The gut mucosal surface is continuously exposed to pathogens, beneficial mutualistic and 
commensal bacteria, and it is armoured with the largest part of the immune system in the 
organism, with lymphocytes scattered in the lamina propria or in organized gut-associated 
lymphoid tissues (GALT) such as the Peyer’s patches of the small intestine and mesenteric 
lymph nodes (MLNs). Those immune cells can discriminate pathogens from harmless 
antigens, preventing an inappropriate immune response to harmless bacteria, thorough 
regulatory mechanisms known as “oral tolerance”, which is an still incompletely  
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understood active nonresponse to dietary and commensal enteric bacteria or food derived 
antigens administered orally, also related to the maintenance of homeostasis in the gut 
(Murphy et al., 2007). The subepithelial dendritic cells (DCs), B cells and T cells, in the 
lamina propria and GALT express a wide range of pattern-recognition receptors (PRRs), 
surface Toll like receptors (TLRs) and intracellular nucleotide-binding oligomerization 
domain (NOD)-like receptors (NLRs), to acquire antigens from the intestinal lumen. Then, 
secreted cytokines and chemokines from DCs will determine tolerance and active immune 
responses against a particular antigen, and whether lymphocyte differentiation, innate, 
adaptive or allergy immune responses will be displayed (Hart et al., 2004). Also intestinal 
epithelial cells (IECs) at the mucosal surface express PRRs and can also secrete cytokines 
and regulatory molecules, therefore, they participate actively in the discrimination of both 
pathogenic and commensal bacteria (Artis, 2008). In the gut, certain Lactobacillus strains have 
been proved to play a remarkable role sustaining the global population balance through 
their ability to synthesize antagonistic compounds that restrain the proliferation of a 
number of pathogens. However, their mutualistic behaviour with the host involves different 
levels of interaction with the intestinal mucosa, resulting in an anti-inflammatory effect and 
restoration of the mucosal homeostasis (Haller et al., 2010). The proinflammatory cytokine 
profiles occasionally induced by some lactobacilli in model systems (Dong et al., 2010) be 
related to the moderate degree of inflammation (physiological inflammation) elicited by some 
commensals and moderate pathogens, and it has been conceived as a beneficial feature that 
creates a state of awareness for a rapid immune defence response against possible infective 
aggressions, while preserving homeostasis (Sansonetti & Medzhitov, 2009). 
1.3 Tools and strategies for genetic manipulation of lactobacilli 
1.3.1 Gene cloning vectors, genetic markers and promoters 
Several constitutive or inducible gene expression systems have been developed for 
lactobacilli (Fang & O'Toole, 2009). The vectors have different parameters such as copy-
number and host-range, they are derivatives of the rolling-circle plasmids pWVO1 or pSH71 
from L. lactis or the theta-type plasmids pAM1 from Enterococcus faecalis (Perez-Arellano et 
al., 2001) and pRV500 from Lactobacillus sakei (Crutz-Le Coq & Zagorec, 2008). Vectors for 
controlled expression are mainly based on genes and promoters involved in bacteriocin 
production, sugar utilization genes and stress resistance. In addition, following the 
production of proteins by LAB using a specific expression vector they should be properly 
folded, targeted and sometimes recovered. Several vectors included secretion cassettes, such 
as those based on the secretion signal of the lactococcal Usp45 protein (Schotte et al., 2000), 
the expression and secretion signals of S-layer proteins (Savijoki et al., 1997), the PrtP signal 
sequence (Kajikawa et al., 2010) or the M6 carboxy-terminal domain to anchor proteins to the 
cell wall (Reveneau et al., 2002). 
The nisin-controlled expression (NICE) system, based on the autoregulation mechanism of 
the bacteriocin nisin, is a very effective expression vector for  production of heterologous 
proteins in LAB (Mierau & Kleerebezem, 2005). The NICE system contains the promoter 
nisA conducting gene expression under the control of the transcriptional regulator NisR, 
which is modulated by phosphorylation due to the histidine-protein kinase NisK immersed 
in the cytoplasmic membrane. The expression of the genes placed behind the PnisA is induced 
by the addition of subinhibitory concentrations of nisin into the culture medium, in such a 
way that increasing amounts of nisin resulted in a linear dose-response curve. Optimization 
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of the NICE system includes the incorporation in the vectors of the nisin immunity gene nisI, 
which resulted in better tolerance of the cells to high amounts of the inducer nisin (Oddone 
et al., 2009). The NICE system was created for expression of genes in L. lactis but it has been 
adapted to other low-GC Gram-positive bacteria including Lactobacillus helveticus 
(Kleerebezem et al., 1997), L. plantarum (Pavan et al., 2000), Lactobacillus brevis (Avall-
Jaaskelainen et al., 2002), L. casei (Hazebrouck et al., 2007), L. salivarius (Sheehan et al., 2006) 
and L. reuteri (Wu et al., 2006). In these species different strategies have been used to express 
the nisRK genes: on a different plasmid in relation to the nisA promoter with the target gene, 
both on the same plasmid or with the nisRK genes inserted into the chromosome. Similar to 
the NICE system, in L. plantarum (Mathiesen et al., 2004) and L. sakei (Axelsson et al., 2003) 
vectors have been developed using a pheromone-regulated bacteriocin promoter and the 
regulatory system of sakacin A production, respectively. The pSIP vector series, based on 
the genes and promoters involved in sakacin A and P, used erythromycin as selection 
marker (Sorvig et al., 2005). In order to developed a potential food-grade expression system 
the erythromycin gene in the pSIP vectors has been replaced by the alr gene, which encodes 
the alanine racemase enzyme that is essential for cell wall biosynthesis (Nguyen et al., 2011). 
In L. casei an integrative vector, pIlac, has been constructed that allowed stable gene 
insertion in the chromosomal lactose operon. The vector is based on the nonreplicative 
plasmid pRV300 and it contains the 3’ end of lacG and the complete lacF gene (Gosalbes et 
al., 2000). Both vectors, pSIP and pIlac, are based on the complementation host/marker 
system, a gene in the host is mutated or deleted, and a wild copy is inserted into the vector. 
Other potential food-grade vectors are based on a selection marker that confers a new ability 
to the host strain. In this sense a vector has been recently developed that contains a bile salt 
hydrolase gene from L. plantarum and which allows the host to grow in media containing 
bile salts (Yin et al., 2011). Bioluminiscence markers have also been used in lactobacilli and 
they are based on genes encoding enzymes that produce light as lux, which encodes 
bacterial luciferase, and gfp that encodes green fluorescence protein (Chang et al., 2003; 
Perez-Arellano & Perez-Martinez, 2003). 
1.3.2 DNA mutagenesis systems: integration and insertion systems, and random 
mutagenesis systems 
There are two principal methods to generate mutations in lactobacilli:  (i) integration, which 
is a rec-dependent recombination of cloned DNA with an homologous locus; (ii) rec-
independent, which involves transposons and insertion elements (Fang & O'Toole, 2009). 
The integration procedures mostly used in LAB are based on vectors able to integrate by 
homologous recombination with known chromosomal genes, causing their disruption by 
inserting foreign genes. The integrative vectors developed for lactobacilli are either based in 
temperature-sensitive replicons such as pG+host, pIP501, pTNI and pGID or non-replicative  
plasmid such as pUC18/19 and pBlueScript SK-. As well, a two plasmids system have also 
been used to direct integration into Lactobacillus chomosomes via homologous 
recombination (Russell & Klaenhammer, 2001). This system utilizes pOWV01-derived 
vectors from which the repA gene has been removed. The repA is supplied in trans in a 
temperature-sensitive helper vector. A subsequent temperature shift selects for loss of the 
helper plasmid and integration of the pOWV01-derived vector. In addition, there are other 
mutagenesis systems as that of the Cre-lox-based system used in L. plantarum (Lambert et al., 
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2007) and site-specific integrative vectors based on prophage fragments (Martin et al., 2000). 
Other important genetic tool used to study chromosomal genes and their regulation in 
lactobacilli is random transposon mutagenesis. The insertional sequence ISS1, combined 
with the thermosensitive pG+ replicon, was used to inactive genes involved in the 
regulation of phenolic acid metabolism in L. plantarum (Gury et al., 2004) and several genes 
in L. salivarius (Mason et al., 2005). Tn5 transposome system was also efficiently used to 
generate a library of transposon insertion mutants in L. casei (Ito et al., 2010). As well, factors 
affecting the reduction of serum cholesterol by L. acidophillus were identified by random 
transposon mutagenesis (Lee et al., 2010). 
2. Lactic acid production 
Lactic acid produced by many LAB is a racemic mixture of L-lactate and D-lactate isomers. 
D-lactate is not metabolized by humans, then L-lactate is the most important isomer for food 
biotechnological applications, and also for pharmaceutical and biopolymers industries. 
Many efforts have been made to construct LAB strains affected in one or several of the 
identified ldh genes, as they can be used in the production through fermentation of non-
racemic, optically active lactic acid. In L. casei BL23, a strain that has been widely used for 
genetic, physiological and biochemical studies, five genes encoding proteins with LDH 
activity have been described (Rico et al., 2008). Mutant strains for those genes demonstrated 
the involvement of each ldh gene in L- and D-lactate formation in this bacterium. Gene ldh1 
codes for an L-LDH responsible for the main synthesis of L-lactate, whilst hicD encodes a D-
hydroxyisocaproate dehydrogenase which renders D-lactate. However, an L. casei BL23 ldh1 
mutant still produced substantial amounts of L-lactate and an increase in the production of 
D-lactate was observed (Viana et al., 2005). D-lactate was probably synthesized via the 
activity of HicD, since it was abolished in a ldh1 hicD double mutant. ldh2, ldh3 or ldh4 
single mutations or combined with an ldh1 deletion (ldh1 ldh2, ldh1 ldh3,ldh1 ldh4) had a 
low impact on L-lactate synthesis showing that ldh2, ldh3 and ldh4 genes play a minor role in 
lactate synthesis (Rico et al., 2008). Comparable behaviour has been reported for many LAB 
where ldhs have been deleted. In this sense, mutation of the genes encoding L- and D-LDHs 
from L. plantarum, an organism which produces a mixture of 50% D- and 50% L-lactate, 
never resulted in a complete lack of lactate production (Ferain et al., 1996). An ldhL mutation 
in L. sakei, a lactic acid bacterium which lacks D-lactate dehydrogenase activity, rendered a 
strain with strongly reduced L- and D- lactate production (the D isomer was a consequence 
of the presence of a racemase activity able to transform L- into D-lactate), but small amounts 
of lactate were still produced (Malleret et al., 1998). Recombinant strategies have also been 
used in Lactobacillus strains to produce lactic acid from sugars others than glucose and from 
biomass such as starch and cellulose. In an L. plantarum ldhL1 strain, that only produced D-
lactate from glucose, the phosphoketolase gene was substituted by a transketolase gene 
from L. lactis, and the resulting L. plantarum ldhL1-xpk1::tkt strain produced 38.6 g/l of D-
lactate from 50 g/l of arabinose (Okano et al., 2009). The production of D-lactate from xylose 
was also achieved in L. plantarum by disrupting a phosphoketolase 2 gene in the L. plantarum 
ldhL1-xpk1::tkt strain and transforming it with a plasmid that contains the genes xylAB. The 
L. plantarum ldhL1 strain was transformed with plasmids expressing amylolytic or 
cellulolytic enzymes, and the resulted strains were able to produce D-lactate from raw corn 
starch or cellulosic compounds, respectively (Okano et al., 2010).  
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In addition to rational methods of metabolic engineering, lactic acid production has also 
been enhanced by a combination of classical strain improvement methods (nitrosoguanidine 
and ultraviolet mutagenesis) with whole-genome shuffling by recursive protoplast fusion. 
In this way, shuffled strains derived from an industrial strain of Lactobacillus have been 
isolated, and they produce threefold more lactic acid than the wild type at pH 4.0 (Patnaik et 
al., 2002). Shuffled L. rhamnosus strains with improved tolerance to glucose and enhanced L-
lactate production has also been obtained (Yasuda et al., 2008). In the same way, a fusant 
derived from Lactobacillus delbueckii able of growing at low pH and utilizing starch from 
cassava bagasse was obtained and it produced large amounts of L-lactic (John et al., 2008).  
3. Diacetyl and acetoin production 
Diacetyl and acetoin are important compounds of buttery flavor in fermented foods and are 
used as additives in the food industry. Both compounds are derived from pyruvate, which 
is converted to -acetolactate by the action of -acetolactate synthase or acetohydroxyacid 
synthase. Then, acetoin is formed by the activity of -acetolactate decarboxylase on -
acetolactate and diacetyl results from a non-enzymatic oxidative decarboxilation of -
acetolactate (Figure 2). Most metabolic engineering approaches to produce diacetyl/acetoin 
by fermentation have been developed in the model LAB L. lactis, in which strains that divert 
an important part of pyruvate flux towards the production of -acetolactate have been 
constructed (Hugenholtz et al., 2000; Lopez de Felipe et al., 1998). ilvBN genes, encoding 
acetohydroxyacid synthase from L. lactis, have been expressed from the lactose operon in L. 
casei, an organism which shows marginal production of diacetyl/acetoin, resulting in 
increased diacetyl formation (Gosalbes et al., 2000). In addition, to enhance diacetyl/acetoin 
production, the amount of pyruvate available for IlvBN was increased by blocking pyruvate 
alternative pathways in L. casei. Thus, the L. casei strain that expresses the ilvBN genes was 
mutated in the ldh gene and in pdhC, encoding the E2 subunit of the pyruvate 
dehydrogenase enzyme. The introduction of these mutations resulted in an increased 
capacity to synthesize diacetyl/acetoin from lactose fermentation in whey permeate (1400 
mg/l at pH 5.5) (Nadal et al., 2009). 
4. Mannitol and sorbitol production 
Sugar alcohols are hydrogenated carbohydrates widely used in the food industry as sugar 
replacers. Mannitol and sorbitol are used as food additives due to their sweetening effect 
(about half as sweet as sucrose) and low calorie content. They are also used in the food and 
pharmaceutical industries due to their technological properties, such as texturing agents, 
humectants, softeners and color stabilizers. In nature, mannitol is found in some plants, 
algae and mushrooms, and sorbitol is found in many fruits and vegetables. Those polyols 
are also produced by fungi, yeast and bacteria, where they play several roles in carbon 
storage and protection during osmotic and oxidative stresses. Industrial production of most 
sugar alcohols is performed by catalytic reduction of sugars with hydrogen gas and nickel at 
high temperature and pressure, for which highly pure sugar substrates and 
costlychromatographic purification steps are required. Regardless the limitations of this 
chemical method, it is until now the only process able to assume the high market demand of 
sorbitol and mannitol, estimated to be thousands of tons per year. However, processes using 
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bacteria  and yeasts have demonstrated that biotechnological production may represent an 
efficient and cost-effective alternative to the chemical production.  
The production of polyols by using genetically engineered LAB has been recently reviewed 
(Monedero et al., 2010). Mannitol is a natural fermentation product in heterofermentative 
LAB, in which the NADH generated during sugar metabolism is regenerated by the 
 
 
Fig. 2. Proposed pathways for sorbitol, mannitol, acetoin and diacetyl production by 
engineered lactic acid bacteria. [1] phosphoenolpyruvate: lactose phosphotransferase 
system, [2] phosphoenolpyruvate: glucose phosphotransferase system, [3] -
phosphogalactosidase, [4] glucokinase, [5] phosphoglucose isomerase, [6] sorbitol-6P 
dehydrogenase, [7] mannitol-1P dehydrogenase, [8] phosphofructokinase, [9] fructose 1,6-
bisP aldolase, [10] galactose-6P isomerase, [11] tagatose-6P kinase, [12] tagatose-1,6DP 
aldolase, [13] triose-phosphate isomerase, [14] lactate dehydrogenase, [15]-acetolactate 
synthase, [16] acetohydroxyacid synthase , [17]-acetolactate decarboxylase, [18] pyruvate 
oxidase, [19] pyruvate dehydrogenase complex, [20] pyruvate-formate lyase. DHAP, 
dihydroxiacetone phosphate. 
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production of lactate and ethanol. However, in the presence of fructose, a mannitol 
dehydrogenase activity (MDH) can account for NADH recycling with the concomitant 
production of mannitol. Homofermentative LAB, which use the glycolytic pathway for 
sugars fermentation and lack MDH, are also able to produce mannitol under special 
circumstances (Figure 2). Mutants of L. plantarum and L. casei impaired in NADH 
regeneration by the lactate dehydrogenase were able to produce small amounts of mannitol 
from glucose due to a mannitol-1-P dehydrogenase (M1PDH) activity on fructose-6P (Ferain 
et al., 1996; Viana et al., 2005). M1PDH can recycle NADH rendering mannitol-1P that can be 
dephosphorylated to mannitol and excreted from the bacterial cell. M1PDH activity is 
generally low, because its gene (mtlD) is only induced by the presence of mannitol. 
Furthermore, mannitol is also a common carbon and energy source that can be fermented. 
Therefore, subsequent re-uptake and metabolism of the produced mannitol should be 
avoided. In bacteria, mannitol is usually taken up by a mannitol-specific 
phosphoenolpyruvate: sugar phosphotransferase system (PTSMtl) which catalizes the 
simultaneous mannitol uptake and phosphorylation to mannitol-1P. L. lactis ldh mutants 
have been constructed which were deleted in mtlA and mtlF, encoding the EIICBMtl and 
EIIAMtl components of the PTSMtl, respectively, involved in mannitol uptake (Gaspar et al., 
2004). This resulted in strains unable to utilize mannitol which converted 33% of the 
fermented glucose into mannitol. In another approach, the M1PDH encoding gene from L. 
plantarum and a gene encoding a mannitol-1P phosphatase from the protozoan parasite 
Eimeria tenella were overexpressed by using the NICE system in an L. lactis ldh mutant 
(Wisselink et al., 2005). This strategy avoided the main bottleneck in mannitol production: 
most mannitol was accumulated inside the cell as mannitol-1P, which could reach 
concentrations up to 76 mM in high density non-growing cells of an L. lactis ldh mutant 
(Neves et al., 2000). In this new strain 50% of the glucose was converted to mannitol 
(maximum theoretical yield of 67%). Other alternatives comprise the expression of MDH 
genes from heterofermenters. The mdh gene from L. brevis was expressed in a L. plantarum 
strain deficient in both ldhL and ldhD genes, and resulted in an increase in mannitol 
synthesis from glucose (Liu et al., 2005).  
The sorbitol (gut) operon of L. casei contained the genes gutCBA, encoding the EII 
component of the sorbitol-specific PTS involved in sorbitol transport and phosphorylation, 
two regulatory genes, gutR and gutM, and the gene gutF, encoding a sorbitol-6P 
dehydrogenase (S6PDH) (Alcantara et al., 2008). A recombinant strain of L. casei with the 
gutF gene integrated in the chromosome at the lactose operon produces sorbitol from 
fructose-6P by reversing the sorbitol catabolic pathway (Nissen et al., 2005) (Figure 2). 
Resting cells of this strain synthesized small amounts of sorbitol from glucose, with a 
conversion rate of 2.4 %. Subsequent inactivation of ldh1 gene, encoding the main LDH (Rico 
et al., 2008) promoted an increment in the conversion rate (4.3 %), suggesting that the 
engineered route provides an alternative pathway for NAD+ regeneration. Once glucose 
was depleted, reutilization of the produced sorbitol by L. casei recombinant strains was 
avoided by deleting gutB gene that encodes the IIBC component of the PTSGut (De Boeck et 
al., 2010). L. casei recombinant strains produced mannitol in addition to sorbitol and this 
polyol mixture was avoided by inactivation of the mtlD gene that encodes a M1PDH. The 
engineered L. casei strain (lac::gutF ldh1 gutB mtlD) produced sorbitol from lactose, the 
milk sugar, in non-growing cells or in growing cells under pH control. Fed-batch 
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fermentations using whey permeate, a waste product from the dairy industry with high 
concentration of lactose, resulted in a conversion rate of 9.4% of lactose into sorbitol (De 
Boeck et al., 2010). L. plantarum has also been metabolically engineered to produce sorbitol 
by constitutive overexpression of either srlD1 or srlD2 genes that encode S6PDH activities in 
a mutant strain deficient in LDH activity (Ladero et al., 2007). Using non-growing or 
growing cells under pH control resulted in a very efficiency conversion rate of about 65% 
and 25%, respectively, of sugar into sorbitol. The different efficiencies were suggested to be 
the result of a higher ATP demand for biomass production in growing cells.  
5. Exopolysaccharides (EPS) production 
Some LAB produced EPS, which are extracellular polysaccharides, with important 
characteristics for the dairy industry. They are used to improve the rheological and textural 
properties of fermented foods. EPS have also potential as food additives and functional food 
ingredients. In this sense they are claimed to act as prebiotics in the intestine (Bello et al., 
2001) and to stimulate the immune system (Vinderola et al., 2006). The synthesis of EPS in 
LAB starts at the glycolytic intermediate glucose-6P, which connects the anabolic pathways 
of biosynthesis of sugar nucleotides, the precursors of the EPS, and the catabolic pathways 
for obtaining energy through the glycolysis (Figure 1). Glucose-6P is converted to glucose-
1P by the -phospoglucomutase (-Pgm) activity, and this sugar phosphate is further 
metabolized to UDP-glucose and UDP-galactose by the consecutively action of enzymes 
UDP-glucose pyrophosphorylase (GalU) and UDP-galactose 4-epimerase (GalE) (Boels et al., 
2001). Glucose-1P is also substrate for dTDP- glucose pyrophosphorylase to produce dTDP-
glucose, which will be further metabolized to dTDP-rhanmnose. Glucose, galactose and 
rhamnose are the principal sugars found in the EPS produced by LAB. The subsequent steps 
in the synthesis of EPS is the assembly of the monosaccharide repeating unit by specific 
glycosyltransferases, the polymerization of the repeating units and the secretion from the 
cell (Welman et al., 2006). The enzymes that participate in these stages are encoded by genes 
that form part of eps gene clusters. Genetic engineering strategies could be applied to one or 
more of those stages involved in the EPS biosynthesis in order to increase the EPS 
production or to modify its composition, however, until now only strains of L. lactis and 
Streptococcus thermophilus have been genetically modified to enhance EPS biosynthesis. In S. 
thermophilus the modification of the levels of the GalU, PgmA and the Leloir route enzymes 
resulted in increased levels of EPS (Levander et al., 2002). Homologous overexpression of a 
complete eps operon in L. lactis resulted in about fourfold increase in EPS production (Boels 
et al., 2003). In Lactobacillus species there are no examples of metabolic engineering strategies 
aimed to produce EPS. In this species the synthesis of EPS has been improved by modifying 
the culture conditions, such as carbon source and pH. As well, chemically induced mutants 
of Lactobacillus species that produce higher amounts of EPS than the parental strain have 
been isolated. The synthesis of EPS by L. casei strain CRL 87 was improved by using 
galactose as carbon source at a controlled pH of 5.0, and the high EPS production was 
correlated with high activity level of the enzymes involve in the synthesis of UDP-sugars 
(Mozzi et al., 2003). Similar approaches were applied for L. helveticus strain ATCC 15807, 
which produces a higher amount of EPS from lactose at pH 4.5 than at pH 6.2, which was 
correlated with higher levels of -Pgm activity (Torino et al., 2005). A L. delbrueckii subesp. 
bulgaricus mutant with improved EPS production has been isolated, and it showed higher 
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amounts of GalU activity, glucose-6P and ATP than the parent strain. These characteristics 
suggest that GalU and -Pgm enzymes play important roles in the synthesis of high EPS 
production. The elevated concentration of ATP in the mutant indicated that the glycolysis 
influence the anabolic route of EPS biosynthesis (Welman et al., 2006). A metabolic 
engineering strategy aimed to direct the carbon flux towards UDP-glucose and UDP-
galactose biosynthesis was successfully applied in L. casei. The galU gene coding for GalU 
enzyme in L. casei strain BL23 was cloned under control of the inducible nisA promoter, and 
the resulting strain showed about an 80-fold increase in GalU activity, a 9-fold increase of 
UDP-glucose and a 4-fold increase of UDP-galactose (Rodriguez-Diaz & Yebra, 2011). L. 
casei strain BL23 does not produce EPS, hence it would be an adequate host for the 
production of heterologous EPS.  
6. Improvement of probiotic properties 
6.1 Adhesion to intestinal epithelial cells 
Adhesion of probiotic bacteria has been employed as a criterion for strain selection and, 
although it is not indispensable for some probiotic traits, it has positive effects on strain 
persistence at the gastrointestinal tract and in pathogen inhibition by displacement and 
competition for adhesion sites. Also, it has been suggested that the capacity to adhere to 
mucosal surfaces influences the cross-talk established between probiotic bacteria and host 
cells (Sanchez et al., 2008; Velez et al., 2007). 
Probiotic strains have shown the ability to bind to intestinal epithelial cultured cells (e.g. 
Caco-2, HT-29), to mucus components and to proteins of the extracellular matrix (ECM) 
such as collagen, fibronectin or laminin. Although theses late molecules are not commonly 
found at the mucosal surface, they may be shed into the mucus or may be exposed in case of 
trauma or inflammation. They are common targets for pathogen adhesion during the 
process of infection and adhesion to them by probiotic bacteria can compete with pathogen 
binding. In contrast to the knowledge about adhesive factors in bacteria causing infectious 
diseases in humans and animals, the knowledge about adhesion mechanisms in probiotics is 
very limited. Some molecules from probiotics have been identified as responsible for 
adhesion, including lipoteichoic acid and exopolysaccharides. However, surface proteins are 
the major responsible for adherence. Typical surface adhesins from pathogenic bacteria with 
binding capacity to cultured cells and ECM components are not found in probiotics 
although it is hypothesized that they may share similar mechanisms for attachment.  Similar 
to some pathogens, probiotic lactobacilli display on their surface moonlighting proteins 
which are in most cases of cytoplasmic location and are exported and retained on bacterial 
surfaces by yet unknown mechanisms. These include glycolytic enzymes such as enolase 
and glyceraldehyde 3-phosphate dehydrogenase (GAPDH), molecular chaperones (DnaK, 
GroEL) and translational elongation factors (EF-Tu, EF-G) (Sanchez et al., 2008; Velez et al., 
2007). These proteins have demonstrated binding ability to ECM proteins and epithelial cells 
and in some cases interfere with host pathways (plasminogen activation mediated by 
enolase  from Lactobacillus crispatus and Lactobacillus johnsonii (Antikainen et al., 2007) or 
immunoregulation by GroEL from L. johnsonii (Bergonzelli et al., 2006). Other surface 
proteins with identified roles in adhesion are surface layer (S-layer) proteins or Slp. S-layers 
from lactobacilli such as L. acidophilus or L. brevis are formed by small basic proteins which 
form a crystalline matrix on the bacterial surface. The real function of the S-layer is uncertain 
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but is has been demonstrated that some Slp proteins display binding capacity to ECM 
proteins and possess immunoregulatory capabilities. In general the adhesive properties of 
the above extracellular proteins did not show a strict specificity for substrate binding and it 
is postulated that they may possess lectin-like characteristics that allow their binding to 
highly glycosylated ECM proteins and mucosal surfaces (Velez et al., 2007).  
6.1.1 Specific proteins implicated in mucus binding 
Species of lactobacilli from intestinal origin (L. plantarum, L. reuteri, Lactobacillus gasseri, L. 
acidophilus, L. johnsonii) express surface proteins covalently anchored to the cell wall by a 
sortase-dependent mechanism with mucus binding ability (Msa and Mub proteins) 
(Boekhorst et al., 2006). They are large multidomain proteins containing up to fifteen tandem 
copies of a mucin-binding domain (MucBP) and act as mannose-dependent adhesins with 
the capacity to aggregate Saccharomyces cerevisiae cells. The presence of these proteins in 
certain L. reuteri isolates correlates with the binding ability to mucus. Similarly, the presence 
in L. plantarum of msa genes is the sole requisite for mucus binding in this species, but 
domain composition and subtle amino acids changes in each specific Msa protein account 
for the diverse adhesion properties reported in different strains.  In L. rhamnosus GG  (LGG), 
a well characterized probiotic with established mucus adhesion properties, the product of 
the LGG_02337 gene is the only protein encoded in the genome which contains four MucBP 
domains about 50 amino acids shorter in length compared to the large mucus binding 
proteins Msa and Mub. This protein is anchored at the bacterial surface and possesses in 
vitro binding activity to mucus (von Ossowski et al., 2011). 
A genome analysis of several L. rhamnosus strains identified the spaCBA cluster as another 
trait responsible for mucus adherence in LGG. This cluster codes for the three components 
of pili structures similar to pili described in Gram-positive pathogens that can be identified 
by immune electron microscopy at the LGG surface (Kankainen et al., 2009). SpaA is the 
major pilin protein that forms the pilus shaft, while SpaC and SpaB are ancillary pilus 
proteins which are present at the pilus tip or along the pilus structure and possess adhesive 
properties. Adhesion experiments with purified proteins, specific antibodies, and mutant 
construction have demonstrated that SpaC and SpaB are responsible for the mucus binding 
activity displayed by LGG. This is the first example of the presence of pili adhesive 
structures in a probiotic strain and exemplifies the adaptation of these bacteria to persist in 
host tissues. 
6.1.2 Engineered lactic acid bacteria with enhanced adhesion 
Some of the adhesion factors characterized in probiotic bacteria may be targets for strain 
engineering aimed to enhance bacterial adhesion. In addition, heterologous expression of 
well characterized adhesins from different sources can be envisaged. This can be useful to 
increase residence times at the gastrointestinal tract, enhance interactions with the mucosal 
immune system and promote competitive exclusion of pathogens by probiotics. Some 
probiotic strains like L. casei Shirota have been engineered to express a fibronectin binding 
domain from the Sfb protein of Streptococcus pyogenes, allowing this strain, which barely 
binds fibronectin, to bind this ECM substrate, fibrinogen and human fibroblasts (Kushiro et 
al., 2001). However, to date most genetic engineering strategies aimed to increase lactic acid 
bacteria adhesion have been carried out in the model L. lactis species. This bacterium is not a 
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normal inhabitant of the gastrointestinal tract but it has been used as a food grade delivery 
vehicle for presenting bioactive molecules to mucosal surfaces, including antigens, cytokines 
or enzymes. Expression of a protein containing a chitin-binding domain from L. plantarum on 
the surface of L. lactis resulted in enhanced capacity to attach to natural compounds carrying 
polymers of N-acetylglucosamine, such as human mucins (Sanchez et al., 2011). The 
recombinant strain also showed increased attachment to epithelial Caco-2 cells. In another 
approach, the receptor binding domain of FedD adhesin from E. coli F18 fimbriae was 
expressed and anchored to the bacterial surface by creating a fusion with the surface anchoring 
domain of the L. lactis autolysin AcmA. This fusion protein promoted the binding of L. lactis to 
porcine intestinal epithelial cells (Lindholm et al., 2004). Finally, expression in L. lactis of either 
a fibronectin binding protein from Staphylococcus aureus or Internalin A from Listeria 
monocytogenes promoted its binding to human epithelial cells and bacterial internalization, 
providing a tool for DNA delivery into eukaryotic cells (Innocentin et al., 2009). 
6.2 Inmunomodulation of colonic mucosa 
In the case of functional properties of lactobacilli, due to legal restrictions and public 
opinion attitudes against the use of genetically modified microorganisms, the most general 
strategy has been the selection of naturally competent probiotic strains, nevertheless, some 
examples of mutants and genetically engineered strains can be found with specific and 
improved properties (see below). The molecular mechanisms underlying this process are 
still unknown, however, intervention studies using probiotics in controlled placebo double 
blind clinical assays are very abundant and different meta-analysis confirmed that several 
specific beneficial effects of probiotics pass very stringent examination criteria (Williams, 
2010), however, they are costly in time and resources and cannot be used to test a great 
number of strains. Hence, this review will initially describe the general features that 
characterise the recognition of bacteria by the mucosa and, then, it will focus on the 
characterisation of the mechanisms of action and the understanding of the effect of 
probiotics on model systems, as a mean efficiently select funtional strains. 
As described in the introduction, the mucosal surface is continuously exposed to both 
potential pathogens and beneficial commensal microorganisms. This creates a requirement 
for a homeostatic balance between tolerance and immunity that represents a unique 
regulatory challenge to the mucosal immune system. Dendritic cells (DCs) in the lamina 
propria efficiently recognise microbial components from the intestinal lumen through PRRs, 
TLRs and NLRs. Then, DC migrate to draining lymph nodes, where they have the unique 
ability to activate and influence functional differentiation of naïve T cells. Signals from DC 
can determine whether tolerance or active immune responses occur to a particular antigen 
and furthermore influence whether a T helper (Th) cells of the type Th1 (innate immune 
response), Th2 (adaptive immune response and allergy), Th17 or Treg (lymphocyte 
differentiation) predominates. The DC subtype, whether CD11c+ (myeloid) or CD11c- 
(plasmacytoid), maturation status, and cytokine production contribute to the type of T cell 
response. For example, when DCs upregulate the coestimulatory molecules CD80 and 
CD86, produce IL-12 which contributes a Th1 response, but if DCs produce IL-10 and IL-4, 
they will promote the generation of a Th2 or regulatory T cells (Hart et al., 2004). 
Furthermore, intestinal epithelial cells (IECs) are not just a simple physical barrier. They 
express TLRs as well as intracellular NLRs and they can secrete cytokines and regulatory 
molecules (TSLP, TGFǃ, IL-10, etc) that regulate cytokine secretion by DCs and 
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macrophages. Therefore, EICs actively participate in the discrimination of both pathogenic 
and commensal bacteria, they are crucial in triggering lymphocyte differentiation, 
maintaining intestinal immune homeostasis and mechanisms of innate defense (Artis, 2008). 
As consequence, commensal bacteria and pathogens are detected at different levels, in IECs, 
DC and macrophages. Different receptors recognise different bacterial ligands, so that the 
mucosa would integrate the information to recognise the microorganisms approaching the 
mucosa. PRRs in IECs and DC binding to bacterial molecular patterns (PAMPs) are 
expressed at the cell surface (TLR2, TLR4, CD14, TLR5) or in specialised endosomes (TLR3, 
TLR7, TLR8, TLR9). They can recognise single bacterial ligands or act synergistically to 
recognise others. As a quick overview, TLR3 recognises double stranded viral RNA, TLR9 
hypomethylated CpG bacterial DNA, TLR7 and TLR8 were reported to recognize small 
imidazoquinoline compounds and TLR4, with the aid of CD14, recognises 
lipopolysaccharides (LPS) and lipoarabinomannans. Peptidoglycan (PGN) of different 
grampositive bacteria have been shown to interact with TLR2 (Iwaki et al., 2002 ), however, 
TLR2 recognises other PAMPs (PGN, lipoteicoic acid, mycobacterial cell walls, protozoan 
parasite GPI anchors, lipoproteins, glycoproteins, glycolipids, LPS, etc). Furthermore, the 
complex TLR2/TLR6 recognises dipalmitoylated mycoplasma lipoprotein (MALP2), phenol 
soluble modulin from Staphylococcus epidermidis and fungal zymosan, and also, TLR2 
associated to TLR1 recognises triacylated lipoproteins such as Borrelia burgdorferi OspA (for 
review see (Qureshi & Medzhitov, 2003)). In addition, cell wall components in lactobacilli 
and firmicutes are recognized by intracellular pattern-recognition molecules members of the 
nucleotide-binding oligomerization domain (NOD) family. The NLR family (also called 
Nod-leucine-rich repeats (LRRs)) are responsible for the signalling response induced by 
bacterial PGN and bacterial surface components, for instance, Nod1/CARD4 receptor in 
macrophages recognises Meso-diaminopimelic acid (meso-DAP),  Nod2/CARD15 
recognises muramyl dipeptide (MDP), Nod2 acting as a general sensor for bacteria, 
Ipaf/CLAN/CARD12 recognises intracellular flagellin (independently of TLR5, which 
senses extracellular flagellin) and cryopyrin/PYPAF1/NALP3 recognises bacterial RNA 
(and endogenous danger signals) and among others (for review, see (Franchi et al., 2006). In 
particular, Nod2 recognizes a PGN motif present on both Gram-positive and Gram-negative 
bacteria. 
6.2.1 Mechanisms of immunomodulation and probiotic factors involved 
Nuclear factor κB (NF-κB) is a transcriptional regulator, or rather a regulator family, that 
controls the expression of hundreds of genes related to different cellular processes, 
including innate and adaptive immune responses. NF-κB signalling is the major pro-
inflammatory pathway controlling the expression of cytokines, chemokines, enzymes that 
produce secondary inflammatory mediators and inhibitors of apoptosis. It is activated by 
numerous proteins, among them pathogen-associated molecular patterns (PAMPs). Various 
lactobacilli have been described to inhibit NF-κB activity (Kim et al., 2008; Petrof et al., 2004). 
Although the initial steps of the process are not known, it was determined that L. casei DN-
114.001 can maintain intestinal homeostasis after an inflammatory stimulus through a 
process that controls the ubiquitin/proteasome pathway upstream of I-kBǂ resulting in the 
stabilization of it, therefore blocking NF-κB for nuclear translocation (Tien et al., 2006). Such 
effects possibly occur through targeting of multiple effectors and, in some cases, through 
complementary pathways such as NF-κB and p38 MAPK signaling pathways as shown in L. 
casei  and L. reuteri where they could play important roles in the augmentation of innate 
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immunity (Iyer et al., 2008; Kim et al., 2006). Two proteins of L. rhamnosus GG (p40 and p75) 
(Yan et al., 2007) have been suggested to preserve the tight junction (TJ) integrity, an effect 
mediated by the PKC and MAPK pathways. They display antiapoptotic activity, prevent 
epithelial barrier damage caused by several agents and show in vivo effect by decreasing the 
susceptibility to dextran sulphate sodium (DSS)-induced colon epithelial injury (Yan et al., 
2007). Interestingly, recent studies (Bäuerl et al., 2010) showed that these proteins are active 
cell wall hydrolases present in the seven genome sequences available for strains in the L. 
casei-paracasei/rhamnosus group. PGNs are cell wall components that interact with the 
intracellular receptor Nod2. Their in vivo effect changes with their composition composition, 
which also varies between strains. In the case of Lactobacillus salivarius Ls33 the 
muropeptide, M-tri-Lys, acts as ligand that protected mice from colitis in a NOD2-
dependent but MyD88-independent manner (Macho Fernandez et al., 2011). 
Two strains of L. reuteri and L. casei, but not L. plantarum, had the ability to prime DC to 
drive the development of Treg cells which produced increased levels of the anti-
inflammatory cytokine IL-10 (Smits et al., 2005). This ability was mediated by binding to the 
C-type lectin DC-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-
SIGN). Targeting of DC-SIGN by certain probiotic bacteria could explain their beneficial 
effect in the treatment of several immune diseases, including atopic dermatitis and Crohn's 
disease. However, a DC-SIGN ligand capacity has been found in an extracellular protein 
(LP_2145) in L. plantarum WCFS1(patent application WO/2009/035330) and in the surface-
layer protein A (SlpA) from L. acidophilus NCFM, inducing IL-10, IL-4 and decreasing 
IL12p70 synthesis (proinflammatory) (Konstantinov et al., 2008). 
There are also experiments that reported the in vivo effect on gene transcription in human 
volunteers where biopsies were analysed by microarrays. Strains of L. rhamosus GG (Di Caro 
et al., 2005) and L. plantarum WCFS1 (van Baarlen et al., 2011) were used administrated and a 
differential expression of analysed, noticing that expression affected mainly to genes 
involved in the immune and inflammatory response, as well as to genes related to 
apoptosis, growth and cell differentiation, signalling, adhesion, etc. Remarkably, striking 
differences were found in the modulation of NF-κB related pathways. 
6.2.2 Engineered lactic acid bacteria 
An efficient expression of IL-10 was achieved in L. lactis , that showed a striking effect in the 
remediation of DSS (dextran sodium sulphate) induced colitis in IL-10-/- mice (Steidler et al., 
2000). Then, the genetic manipulation strategy was improved and the human IL-10 encoding 
gene used to replace the thymidylate synthase gene (thyA) in the bacterial chromosome, which 
achieved a stable genetic construction and a self contained recombinant strain requiring 
thymidine to proliferate. This strain was used in a double blind assay on Crohn’s disease 
patients (phase I), proving that the intake of this strain significantly decreased the disease 
activity (Braat et al., 2006). Other anti-inflammatory and epithelium repairing peptide, such as 
the trefoil factor, was similarly successful in mice (Vandenbroucke et al., 2004). 
Mutants obtained by site directed mutagenesis, holding genetic changes precisely 
introduced, have been tested for improved health features. Teichoic acids (TA) activate 
NF-B through TLR-2 binding and they are one of the main immunostimulatory 
components of pathogenic grampositive bacteria. This effect was also observed in L. 
plantarum NCIMB8826, however, a mutant (dlt) deficient in D-alanylation of TA was much 
more anti-inflammatory than the parental strain on peripheral blood mononuclear cells 
and mice (Grangette et al., 2005). 
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In other cases mutants have been very useful to demonstrate the functional effect of certain 
cell components. In L. casei Shirota (LcS), a mutant strain was very useful to prove that 
inhibition of the pro-inflammatory cytokine IL-6, through Nod2/ NF-B, was due to a cell 
wall-derived polysaccharide– PGN complex (PSPG) (Matsumoto et al., 2009). 
6.3 Engineered probiotics to delivery bioactive proteins 
The ability of lactobacilli to survive on the mucosal surfaces of humans and animals has 
been utilized for the delivery and presentation of bioactive molecules at these surfaces. 
These bacteria have several advantages, including their recognised GRAS/QPS status, their 
capacity to interact with the host at several levels and their public acceptance. Studies of 
lactobacilli as delivery vehicles have mainly focused on the development of mucosal 
vaccines. In addition, interleukins have been also co-expressed with antigens in lactobacilli 
to enhance the immune response. Other applications of Lactobacillus species as delivery 
systems include anti-infectives, therapies for allergic diseases and therapies for 
gastrointestinal diseases. The ability of lactobacilli and other LAB to express these 
antigens/bioactive molecules at mucosal surfaces have been widely reviewed (Monedero & 
Pérez-Martínez, 2008; Wells & Mercenier, 2008). 
Some recent examples include the use of Lactobacillus jensenii strains isolated from human 
vaginal mucosa for the delivery vehicle of a surface-anchored two-domain CD4 (2D CD4) 
molecule for the mitigation of heterosexual transmission of HIV (Liu et al., 2008). L. casei was 
the host to express the viral proteins from porcine rotavirus and porcine parvovirus fused 
the heat-labile toxin B subunit from Escherichia coli. The results showed that mice responded 
producing increased levels of anti-viral antibodies (Liu et al., 2011). L. casei Zhang was 
engineered to stably express the p23 immunodominant surface protein of Cryptosporidium 
parvum sporozoites. Recombinant L. casei Zhang-p23 was able to activate the mucosal 
immune system and to elicit specific serum immunoglobulin G (IgG) and mucosal IgA in 
mice. The expression of cytokines such as IL4, IL6, and IFN-gamma was detected in 
splenocytes of mice by real-time PCR after oral immunization with this strain (Geriletu et al., 
2011). A recombinant L. casei strain secreting biologically active murine interleukin-1has 
been constructed. This strain was able to induce IL8 secretion in Caco2 cells and IL6 in vivo 
using a ligated-intestinal-loop assay in mice after oral administration. The increased 
adjuvant properties of this strain were confirmed after intragastric immunization with heat-
killed Salmonella enterica serovar Enteritidis (Kajikawa et al., 2010). 
Another application of lactobacilli has been their use to express molecules to deliver passive 
immunity against pathogens, such as single-chain antibodies (lactobodies). Martin and co-
workers have been able to construct a series of expression cassettes stably integrated in the 
chromosome to mediate the secretion or surface display of antibody fragments in Lactobacillus 
paracasei. These new constructed strains, producing surface-anchored variable domain of llama 
heavy chain (VHH) (ARP1) directed against rotavirus, showed efficient binding to rotavirus 
and protection in the mouse model of rotavirus infection (Martin et al., 2011). 
Lactobacilli can also be engineered to produce an increased immune response against cancer 
cells. L. rhamnosus GG (LGG) has been used to successfully induce tumor regression in an 
orthotopic model of bladder cancer. The potential of LGG to induce a directed anti-tumor 
response was evaluated with modified LGG secreting the prostate specific antigen (PSA) or 
IL15 and PSA (IL-15-PSA). Recombinant LGG activated neutrophils, induced dendritic cells 
maturation, T cell proliferation and PSA specific cytotoxic T lymphocytes activity leading to 
the tumor regression (Kandasamy et al., 2011). 
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In spite of the dozens of reports describing the capacity of LAB to deliver bioactive 
molecules to the host mucosa, important issues, such as potential side-effects should be 
always addressed when working with recombinant LAB. The expression of the Salmonella 
OmpC in a recombinant L. casei was fortuitously found to reduce the secretion of tumor 
necrosis factor alpha (TNF-) from murine macrophages (Kajikawa & Igimi, 2009). Another 
non desired effect of a recombinant Lactobacillus was found when L. acidophilus was 
engineered to express the interferon- to study the local delivery of this molecule in a colitis 
mouse model. Surprisingly the administration of the recombinant bacteria secreting IFN- 
has an immunological effect that resulted in the exacerbation of colitis in this model 
(McFarland et al., 2011). 
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